Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
Robert J. Fox(Cleveland Clinic), Jens Kühle(University of Basel), Christian Barro(Brigham and Women's Hospital), Eric C. Klawiter(Harvard University), Marianne Chase(Massachusetts General Hospital), Andrew Goodman, Robert T. Naismith(Washington University in St. Louis), Victoria König(Cleveland Clinic), Christopher S. Coffey(University of Iowa), Paola Raska(Cleveland Clinic), Robert Bermel(Cleveland Clinic), Matthew Karafa(Cleveland Clinic)
Cited by 47
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
|Science|2022|2k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572